Forte Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2016 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Forte Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2016 to Q2 2024.
Forte Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $802K, a 6.2% decline year-over-year.
Forte Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $3.16M, a 9.69% decline year-over-year.
Forte Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.28M, a 18.2% decline from 2022.
Forte Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.02M, a 4.72% decline from 2021.
Forte Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.21M, a 341% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$3.16M	$802K	-$53K	-6.2%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$3.21M	$805K	-$72K	-8.21%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$3.28M	$780K	-$80K	-9.3%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-18
Q3 2023	$3.36M	$772K	-$134K	-14.8%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$3.5M	$855K	-$339K	-28.4%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-14
Q1 2023	$3.84M	$877K	-$178K	-16.9%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-13
Q4 2022	$4.02M	$860K	-$378K	-30.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-18
Q3 2022	$4.39M	$906K	-$567K	-38.5%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	$4.96M	$1.19M	+$186K	+18.5%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	$4.77M	$1.06M	+$560K	+113%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	$4.21M	$1.24M	+$683K	+123%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-31
Q3 2021	$3.53M	$1.47M	+$1.1M	+293%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	$2.43M	$1.01M	+$984K	+4100%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021	$1.45M	$495K	+$493K	+24650%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-16
Q4 2020	$956K	$555K	+$3.52M		Oct 1, 2020	Dec 31, 2020	10-K	2022-03-31
Q3 2020	-$2.57M	$375K	+$373K	+18650%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-08
Q2 2020	-$2.94M	$24K	-$976K	-97.6%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-16
Q1 2020	-$1.96M	$2K	-$2M	-99.9%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-10
Q4 2019	$36K	-$2.97M	-$4.72M	-269%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-16
Q3 2019	$4.75M	$2K	-$1.93M	-99.9%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-09
Q2 2019	$6.68M	$1M	-$672K	-40.2%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	$7.35M	$2M	+$479K	+31.5%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-04-23
Q4 2018	$6.87M	$1.75M	+$375K	+27.3%	Oct 1, 2018	Dec 31, 2018	10-K	2020-02-27
Q3 2018	$6.5M	$1.93M	+$436K	+29.2%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018	$6.06M	$1.67M	+$616K	+58.3%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018	$5.44M	$1.52M	+$992K	+188%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-07
Q4 2017	$4.45M	$1.38M	+$972K	+241%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-27
Q3 2017	$3.48M	$1.49M	+$1.18M	+372%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-08
Q2 2017	$2.3M	$1.06M	+$717K	+212%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-09
Q1 2017	$1.59M	$529K	+$264K	+99.6%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-11
Q4 2016	$1.32M	$403K			Oct 1, 2016	Dec 31, 2016	10-K	2019-02-27
Q3 2016		$316K			Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-08
Q2 2016		$339K			Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-09
Q1 2016		$265K			Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.